UPLP Inhibitors
The chemical class referred to as UPLP Inhibitors comprises a diverse group of compounds that can potentially activate the UPLP protein through various mechanisms. These activators target different cellular pathways involved in UPLP activation and function. A769662, Forskolin, and Berberine, as AMPK activators, can influence cellular energy status and metabolism, indirectly supporting UPLP activation by activating AMPK.
Resveratrol, a SIRT1 activator, may activate UPLP by modulating SIRT1 activity, impacting cellular processes that contribute to UPLP activation and enhanced cellular function. Ionomycin, a calcium ionophore, can potentially activate UPLP by increasing intracellular calcium levels, influencing signaling pathways involved in UPLP activation. Metformin and Nicotinamide Riboside, both AMPK activators, can modulate AMPK activity, leading to cellular responses that support UPLP activation and contribute to improved cellular function.
GW501516, a PPARδ agonist, can activate UPLP by modulating PPARδ activity, leading to downstream effects that support UPLP activation and contribute to enhanced cellular processes and metabolic functions. Dibutyryl cAMP, a cell-permeable cAMP analog, can activate UPLP by mimicking the effects of Forskolin, increasing intracellular cAMP levels and activating PKA. These activators provide a valuable toolbox for researchers studying UPLP, offering insights into the intricate regulatory networks associated with its activation and function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662, an AMPK activator, can potentially activate UPLP indirectly. By activating AMP-activated protein kinase (AMPK), A769662 may influence cellular energy status and metabolism, indirectly supporting UPLP activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a SIRT1 activator, can activate UPLP by modulating SIRT1 activity. SIRT1, a class III histone deacetylase, may influence cellular processes that can contribute to UPLP activation and enhanced cellular function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin, a calcium ionophore, can potentially activate UPLP by increasing intracellular calcium levels. Elevated calcium levels can influence signaling pathways involved in UPLP activation and support its cellular functions. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine, an AMPK activator, can activate UPLP indirectly by influencing AMPK activity. Activation of AMPK by berberine may lead to cellular responses that can support UPLP activation and enhance cellular processes. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMPK activator, can activate UPLP by modulating AMPK activity. By mimicking AMP, AICAR activates AMPK, leading to downstream effects that can support UPLP activation and contribute to enhanced cellular function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG), an AMPK activator, can activate UPLP by influencing AMPK activity. EGCG's activation of AMPK may lead to cellular responses that support UPLP activation and contribute to improved cellular function. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin, an AMPK activator, can activate UPLP by modulating AMPK activity. Its influence on AMPK may lead to cellular responses that support UPLP activation, contributing to enhanced cellular processes and overall cellular health. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
Nicotinamide riboside, an NAD+ precursor, can activate UPLP indirectly. By increasing cellular NAD+ levels, nicotinamide riboside may influence sirtuin activity and other NAD+-dependent processes, potentially supporting UPLP activation. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516, a PPARδ agonist, can activate UPLP by modulating PPARδ activity. Activation of PPARδ may lead to downstream effects that support UPLP activation and contribute to enhanced cellular processes and metabolic functions. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP, a cell-permeable cAMP analog, can activate UPLP by mimicking the effects of forskolin. It increases intracellular cAMP levels, activating PKA and influencing downstream events that support UPLP activation. | ||||||